TY - JOUR T1 - Predicting the impact of asymptomatic transmission, non-pharmaceutical intervention and testing on the spread of COVID19 JF - medRxiv DO - 10.1101/2020.04.16.20068387 SP - 2020.04.16.20068387 AU - Ira B. Schwartz AU - James Kaufman AU - Kun Hu AU - Simone Bianco Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/22/2020.04.16.20068387.abstract N2 - We introduce a novel mathematical model to analyze the effect of removing non-pharmaceutical interventions on the spread of COVID19 as a function of disease testing rate. We find that relaxing interventions has a strong impact on the size of the epidemic peak as a function of intervention removal time. We show that it is essential for predictive models to explicitly capture transmission from asymptomatic carriers and important to obtain precise information on asymptomatic transmission by testing. The asymptomatic reservoir, reported to account for as much as 85% of transmission, will contribute to resurgence of the epidemic if public health interventions are removed too soon. Use of more basic models that fail to capture asymptomatic transmission can result in large errors in predicted clinical caseload or in fitted epidemiological parameters and, therefore, may be unreliable in estimating the risk of a second wave based on the timing of terminated interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBS acknowledges support from the NRL Base funding no. N0001420WX00410, as well as the Office of Naval Research no. N00001419WX01322Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo relevant data is present in the article ER -